Wikidata

(Q83585186)

English

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis

scientific article published on 01 March 2012

In more languages

Statements

title
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
22395585
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395585%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q83585186&oldid=1521036988"